IGF-MTX Conjugate

IGF-MTX Conjugate · IGF Oncology, LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGF-MTX Conjugate, covering 2024-05-21 to 2024-05-21. Get the full timeline:

Most recent: Clinical Trial Update: IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome [Phase 1, Phase 2]